Viewing nowCombinationJadiplozin M Tablet 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 202302697 · Approved 2023.09.11 · Insurance code 661905800
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps control blood sugar levels in adult patients with type 2 diabetes by combining empagliflozin and metformin. When used alongside dietary and exercise therapy, it can effectively improve blood sugar management. It is particularly suitable for adult patients with type 2 diabetes whose blood sugar is not sufficiently controlled and should be used with caution in patients with cardiovascular disease, under the guidance of a specialist. This medication enhances blood sugar control and aids in the treatment of diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin to this medicine should take the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to a CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
This medication is used for the treatment of diabetes and helps in controlling blood sugar. However, it may cause a rare side effect known as severe lactic acidosis, so patients with poor kidney function or liver issues should not use it. Additionally, there is a risk of hypoglycemia when used in conjunction with insulin or sulfonylureas, so caution is advised. The dosage of this medication may be limited based on kidney function, and it should be avoided in special circumstances like acute kidney injury, severe infections, dehydration, or heart failure. This medication should be temporarily discontinued before and after exams using iodine contrast agents and resumed only after kidney function has returned to normal. Pregnant or nursing women should not take this medication, nor is it recommended for children under 18 years of age. During the course of treatment, side effects such as fluid loss, low blood pressure, urinary infections, and genital infections may occur, so symptoms should be carefully monitored. Hypoglycemia symptoms may occur, so caution is needed with irregular meals or intense exercise. Also, this medication can lower vitamin B12 levels, necessitating regular blood tests. Alcohol intake may increase the risk of lactic acidosis, so it is advisable to avoid it while taking this medication. Those with planned surgeries or acute illnesses should also temporarily discontinue this medication. This medication may interact with other drugs, so patients taking other medications should consult with their healthcare provider. Elderly individuals are at risk for decreased kidney function, so dose adjustments and regular monitoring of kidney function are necessary. In case of overdose, blood dialysis may be required, so it is important to adhere to the prescribed dosage. Finally, store this medication out of the reach of children and keep it in its original container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air and moisture. It is best to keep it at room temperature between 1°C and 30°C.
Light brownish-purple, biconvex oval film-coated tablet
30 tablets/bottle, 60 tablets/bottle, 10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.